Potter Sequence Recurrence Risk: Genetic Counseling Is Essential

Potter sequence (renal agenesis/dysgenesis → oligohydramnios → pulmonary hypoplasia, limb contractures, characteristic facies) is a phenotypic endpoint with heterogeneous etiologies. Recurrence risk depends entirely on the underlying cause.

Etiologic Categories

  • Genetic: Autosomal recessive (GREB1L, ITGA8, RET), autosomal dominant (HNF1B, PAX2), chromosomal (22q11.2 del, trisomy 18).
  • Environmental/Teratoigenic: ACE inhibitors, ARBs, NSAIDs (1st trimester), maternal diabetes (poor control), infections (CMV, toxo).
  • Multifactorial: Gene-environment interaction.

Recurrence Risk Estimates

  • Identified autosomal recessive mutation: 25% (1 in 4).
  • Identified autosomal dominant mutation: 50% (if parent affected) or low (de novo).
  • Chromosomal anomaly: Depends on parental karyotype (balanced translocation → up to 10–15%; de novo → <1%).
  • No genetic cause found (isolated): Empiric recurrence ~1–3% (higher than population baseline ~0.1%).

Action Plan for Future Pregnancies

  1. Referral to clinical geneticist / maternal-fetal medicine specialist.
  2. Parental genetic testing (if fetal DNA available — array, exome, targeted panel).
  3. Targeted prenatal ultrasound (renal anatomy, amniotic fluid) at 14–16 weeks and serially.
  4. Preimplantation genetic testing for monogenic disorders (PGT-M) if mutation identified.
  5. Avoid teratogens (ACEi, ARBs, NSAIDs) preconception and throughout pregnancy.

General statistics are insufficient—personalized counseling based on etiologic diagnosis is the standard of care.

Multiple Sclerosis - Related Articles